The Virginia Cannabis Control Authority (CCA) has selected Metrc to run its new seed-to-sale tracking program for the Virginia medical cannabis industry. Launching in the early summer of 2025, this system will be required for all medical cannabis pharmaceutical processors. It will track cannabis through its growth cycle, to production, to sale – helping increase consumer protection, enforcement, and transparency.
One of the key benefits for consumers is the ability to ensure product safety and quality. The system will allow the CCA to quickly manage product recalls, prevent cannabis from being diverted outside the regulated system, and block untested, illicit cannabis from entering the market.
"The new seed-to-sale system will enhance our ability to regulate the medical cannabis market and protect consumers," said Jeremy Preiss, Acting Head and Chief Officer of Regulatory, Policy, and External Affairs for the CCA. "We are pleased to partner with Metrc, which has an established track record for timely implementation of seed-to-sale solutions in other states. This system will enhance the security and safety of the Commonwealth's medical cannabis program."
The system will also provide a wealth of real-time data, offering deeper insights into Virginia's medical cannabis market and consumption trends. This data will inform regulatory decisions and public health education.